{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:28:59Z","timestamp":1782516539119,"version":"3.54.5"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070796"],"award-info":[{"award-number":["82070796"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Trace Elements in Medicine and Biology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jtemb.2022.127040","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T02:32:55Z","timestamp":1657852375000},"page":"127040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Antigen-specific immunotherapies in type 1 diabetes"],"prefix":"10.1016","volume":"73","author":[{"given":"Xuejiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtemb.2022.127040_bib1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/nature08933","article-title":"Genetics, pathogenesis and clinical interventions in type 1 diabetes","volume":"464","author":"Bluestone","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jtemb.2022.127040_bib2","first-page":"359","article-title":"Management of type 1 diabetes","volume":"28","author":"De Beaufort","year":"2018","journal-title":"Med Sante Trop."},{"key":"10.1016\/j.jtemb.2022.127040_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jtemb.2022.127040_bib4","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMra032425","article-title":"Islet transplantation as a treatment for diabetes - a work in progress","volume":"350","author":"Robertson","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MED.0b013e32834803ae","article-title":"2011 Update: antigen-specific therapy in type 1 diabetes","volume":"18","author":"Michels","year":"2011","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.jtemb.2022.127040_bib6","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.2337\/db11-1723","article-title":"Mechanisms underlying antigen-specific tolerance of stable and convertible Th17 cells during suppression of autoimmune diabetes","volume":"61","author":"Wan","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11892-013-0405-9","article-title":"Novel diabetes autoantibodies and prediction of type 1 diabetes","volume":"13","author":"Wenzlau","year":"2013","journal-title":"Curr. Diab Rep."},{"key":"10.1016\/j.jtemb.2022.127040_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/jalm\/jfab113","article-title":"Practical clinical applications of islet autoantibody testing in type 1 diabetes","volume":"7","author":"Winter","year":"2022","journal-title":"J. Appl. Lab Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib9","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00125-017-4308-1","article-title":"Early prediction of autoimmune (type 1) diabetes","volume":"60","author":"Regnell","year":"2017","journal-title":"Diabetologia"},{"issue":"Suppl","key":"10.1016\/j.jtemb.2022.127040_bib10","first-page":"S8","article-title":"Classification and diagnosis of diabetes","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib11","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1055\/a-0984-5696","article-title":"Therapy of type 1 diabetes","volume":"127","author":"Haak","year":"2019","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00398061","article-title":"Long-term risk of IDDM in first-degree relatives of patients with IDDM","volume":"37","author":"Lorenzen","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.jtemb.2022.127040_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3205","article-title":"Past, present and future of latent autoimmune diabetes in adults","volume":"36","author":"Liu","year":"2020","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.jtemb.2022.127040_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049213","article-title":"Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD\/scid\/IL2RG null mice","volume":"7","author":"Unger","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jtemb.2022.127040_bib15","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db10-1797","article-title":"How does type 1 diabetes develop?: the notion of homicide or \u03b2-cell suicide revisited","volume":"60","author":"Atkinson","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2009.07.008","article-title":"T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event","volume":"31","author":"Lennon","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jtemb.2022.127040_bib17","first-page":"80","article-title":"Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes","volume":"97","author":"Sutherland","year":"1984","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"10.1016\/j.jtemb.2022.127040_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cei.12687","article-title":"Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model","volume":"182","author":"Gibson","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib19","doi-asserted-by":"crossref","first-page":"191ra82","DOI":"10.1126\/scitranslmed.3006103","article-title":"Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8(+) T cells in type 1 diabetes","volume":"5","author":"Roep","year":"2013","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nm0402-399","article-title":"Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice","volume":"8","author":"Greeley","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jtemb.2022.127040_bib21","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2337\/dc09-0934","article-title":"Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1","volume":"32","author":"Orban","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib22","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jtemb.2022.127040_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/jc.2009-1365","article-title":"Clinical applications of diabetes antibody testing","volume":"95","author":"Bingley","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jtemb.2022.127040_bib24","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJMra1911109","article-title":"Tolerance in the Age of Immunotherapy","volume":"383","author":"Bluestone","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib25","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib26","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","article-title":"Genetic risk factors for type 1 diabetes","volume":"387","author":"Pociot","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jtemb.2022.127040_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2337\/db15-0779","article-title":"Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes","volume":"65","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11892-016-0738-2","article-title":"Islet autoantibodies","volume":"16","author":"Lampasona","year":"2016","journal-title":"Curr. Diab Rep."},{"key":"10.1016\/j.jtemb.2022.127040_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00003.2010","article-title":"Type 1 diabetes: etiology, immunology, and therapeutic strategies","volume":"91","author":"van Belle","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jtemb.2022.127040_bib30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nri2787","article-title":"Immune cell crosstalk in type 1 diabetes","volume":"10","author":"Lehuen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib31","first-page":"1880","article-title":"Type 1 diabetes TrialNet study G, Teplizumab in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"Reply N. Engl. J. Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Type 1 diabetes TrialNet Study G, Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib33","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/dc18-0494","article-title":"Type 1 diabetes TrialNet ATGGSG, low-dose anti-thymocyte globulin (ATG) preserves beta-cell function and improves HbA1c in new-onset type 1 diabetes","volume":"41","author":"Haller","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib34","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/dc18-0494","article-title":"Preserves \u03b2-cell function and improves HbA in new-onset type 1 diabetes","volume":"41","author":"Haller","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib35","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41590-020-0744-z","article-title":"Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes","volume":"21","author":"Edner","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib36","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI81722","article-title":"Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients","volume":"125","author":"Rigby","year":"2015","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.jtemb.2022.127040_bib37","doi-asserted-by":"crossref","first-page":"6581213","DOI":"10.1155\/2021\/6581213","article-title":"The Multiple Roles of B Lymphocytes in the onset and treatment of type 1 diabetes: interactions between B Lymphocytes and T cells","volume":"2021","author":"Xiao","year":"2021","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.jtemb.2022.127040_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s10020-022-00447-y","article-title":"Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes","volume":"28","author":"Ling","year":"2022","journal-title":"Mol. Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2174\/1573399812666160427104157","article-title":"Beta-cell specific autoantibodies: are they just an indicator of type 1 diabetes?","volume":"13","author":"Fousteri","year":"2017","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.jtemb.2022.127040_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.746187","article-title":"Regulatory B cells: role in type 1 diabetes","volume":"12","author":"Boldison","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib41","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.abh1654","article-title":"Immunotherapy: Building a bridge to a cure for type 1 diabetes","volume":"373","author":"Bluestone","year":"2021","journal-title":"Sci. N. Y."},{"key":"10.1016\/j.jtemb.2022.127040_bib42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/dc13-0626","article-title":"B-lymphocyte depletion with rituximab and \u03b2-cell function: two-year results","volume":"37","author":"Pescovitz","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib43","article-title":"Peptide-MHC-based nanomedicines for the treatment of autoimmunity: engineering, mechanisms, and diseases","volume":"11","author":"Serra","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijpharm.2019.03.041","article-title":"Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy","volume":"562","author":"Dul","year":"2019","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.jtemb.2022.127040_bib45","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/acsbiomaterials.9b00332","article-title":"Dual-sized microparticle system for generating suppressive dendritic cells prevents and reverses type 1 diabetes in the nonobese diabetic mouse model","volume":"5","author":"Lewis","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jtemb.2022.127040_bib46","article-title":"Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides","volume":"32","author":"Singh","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jtemb.2022.127040_bib47","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.1701746114","article-title":"Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease","volume":"114","author":"Pishesha","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jtemb.2022.127040_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113992","article-title":"Red blood cells: the metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers","volume":"178","author":"Glassman","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jtemb.2022.127040_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.657768","article-title":"Emerging therapeutics for immune tolerance: tolerogenic vaccines, T cell therapy, and IL-2 therapy","volume":"12","author":"Moorman","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib50","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.ymthe.2017.04.015","article-title":"Controlled delivery of single or multiple antigens in tolerogenic nanoparticles using peptide-polymer bioconjugates","volume":"25","author":"Pearson","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jtemb.2022.127040_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054712","article-title":"Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice","volume":"8","author":"Sarikonda","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jtemb.2022.127040_bib52","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.2337\/db12-1175","article-title":"Combination treatment with anti-CD20 and oral anti-CD3 prevents and reverses autoimmune diabetes","volume":"62","author":"Hu","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MED.0000000000000547","article-title":"Endotypes in T1D: B lymphocytes and early onset","volume":"27","author":"Smith","year":"2020","journal-title":"Curr. Opin. Endocrinol., Diabetes, Obes."},{"key":"10.1016\/j.jtemb.2022.127040_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/dom.14723","article-title":"Combined therapy with CD4 CD25highCD127 T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: Randomized phase I\/II trial","author":"Zieli\u0144ski","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jtemb.2022.127040_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100965","article-title":"Advances in encapsulation and delivery strategies for islet transplantation","volume":"10","author":"Wu","year":"2021","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.jtemb.2022.127040_bib56","article-title":"Islet encapsulation: new developments for the treatment of type 1 diabetes","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib57","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1177\/15353702211040503","article-title":"Islet cell encapsulation - application in diabetes treatment","volume":"246","author":"Opara","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.jtemb.2022.127040_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2021.05.039","article-title":"Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes","volume":"133","author":"Samojlik","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jtemb.2022.127040_bib59","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(19)31334-0","article-title":"Advances in \u03b2-cell replacement therapy for the treatment of type 1 diabetes","volume":"394","author":"Vantyghem","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jtemb.2022.127040_bib60","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrd.2016.232","article-title":"Advances in islet encapsulation technologies","volume":"16","author":"Desai","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jtemb.2022.127040_bib61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/eje.1.01982","article-title":"Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study","volume":"153","author":"Vald\u00e9s-Gonz\u00e1lez","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jtemb.2022.127040_bib62","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2249.2010.04273.x","article-title":"Long-term follow-up of patients with type 1 diabetes transplanted with neonatal pig islets","volume":"162","author":"Valdes-Gonzalez","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib63","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2337\/dc09-0744","article-title":"Safety and viability of microencapsulated human islets transplanted into diabetic humans","volume":"32","author":"Tuch","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3727\/096368909788341252","article-title":"Effect of micro- and macroencapsulation on oxygen consumption by pancreatic islets","volume":"18","author":"Cornolti","year":"2009","journal-title":"Cell Transpl."},{"key":"10.1016\/j.jtemb.2022.127040_bib65","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2249.2010.04273.x","article-title":"Long-term follow-up of patients with type 1 diabetes transplanted with neonatal pig islets","volume":"162","author":"Valdes-Gonzalez","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib66","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/978-981-15-0602-4_28","article-title":"Autophagy and immune tolerance","volume":"1206","author":"Wu","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jtemb.2022.127040_bib67","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J. Intern Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib68","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.semarthrit.2018.09.008","article-title":"Therapeutic tolerance in autoimmune disease","volume":"48","author":"Rayner","year":"2018","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.jtemb.2022.127040_bib69","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/0192623320948805","article-title":"Opinion on immune tolerance therapeutic development","volume":"48","author":"Radi","year":"2020","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jtemb.2022.127040_bib70","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.seminoncol.2012.10.001","article-title":"Immune tolerance and transplantation","volume":"39","author":"Alpdogan","year":"2012","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.jtemb.2022.127040_bib71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng0397-289","article-title":"Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus","volume":"15","author":"Vafiadis","year":"1997","journal-title":"Nat. Genet"},{"key":"10.1016\/j.jtemb.2022.127040_bib72","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ni.3731","article-title":"The multiple pathways to autoimmunity","volume":"18","author":"Theofilopoulos","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib73","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaut.2016.05.009","article-title":"Maintenance of peripheral tolerance to islet antigens","volume":"72","author":"Hamilton-Williams","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtemb.2022.127040_bib74","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00281-019-00741-8","article-title":"Treg cells in autoimmunity: from identification to Treg-based therapies","volume":"41","author":"G\u00f6schl","year":"2019","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.jtemb.2022.127040_bib75","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-immunol-100219-020937","article-title":"Regulatory T cell development","volume":"38","author":"Savage","year":"2020","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib76","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ni.1760","article-title":"Foxp3+ regulatory T cells: differentiation, specification, subphenotypes","volume":"10","author":"Feuerer","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib77","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat. Rev. Drug Disco"},{"key":"10.1016\/j.jtemb.2022.127040_bib78","first-page":"39","article-title":"Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications","volume":"380","author":"Roncarolo","year":"2014","journal-title":"Curr. Top. Microbiol Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib79","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jtemb.2022.127040_bib80","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.176.8.4748","article-title":"Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells","volume":"176","author":"Ono","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib81","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.0105-2896.2005.00248.x","article-title":"The stages of type 1A diabetes: 2005","volume":"204","author":"Gianani","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jtemb.2022.127040_bib82","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00002281-200307000-00010","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis","volume":"15","author":"Gambineri","year":"2003","journal-title":"Curr. Opin. Rheuma"},{"key":"10.1016\/j.jtemb.2022.127040_bib83","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1084\/jem.20011845","article-title":"CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer","volume":"196","author":"Tarbell","year":"2002","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib84","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2337\/db11-1293","article-title":"Islet \u03b2-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model","volume":"61","author":"Tersey","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib85","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1084\/jem.20020991","article-title":"Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node","volume":"196","author":"Scheinecker","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtemb.2022.127040_bib86","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11892-017-0878-z","article-title":"Combination immunotherapy for Type 1 diabetes","volume":"17","author":"Bone","year":"2017","journal-title":"Curr. Diab Rep."},{"key":"10.1016\/j.jtemb.2022.127040_bib87","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2337\/db19-0057","article-title":"Low-dose anti-thymocyte globulin preserves c-peptide, reduces HbA(1c), and increases regulatory to conventional T-cell ratios in new-onset type 1","volume":"68","author":"Haller","year":"2019","journal-title":"Diabetes: Two-Year Clin. Trial Data Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib88","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jtemb.2022.127040_bib89","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3389\/fimmu.2018.01169","article-title":"Tolerogenic dendritic cells as a promising antigen-specific therapy in the treatment of multiple sclerosis and neuromyelitis optica from preclinical to clinical trials","volume":"9","author":"Fl\u00f3rez-Grau","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib90","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood-2016-02-702852","article-title":"Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease","volume":"128","author":"Koreth","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtemb.2022.127040_bib91","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fimmu.2018.00233","article-title":"Engineered T regulatory type 1 cells for clinical application","volume":"9","author":"Gregori","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib92","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2337\/db18-1321","article-title":"Deficiency of ZnT8 promotes adiposity and metabolic dysfunction by increasing peripheral serotonin production","volume":"68","author":"Mao","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib93","doi-asserted-by":"crossref","first-page":"21432","DOI":"10.1074\/jbc.M115.645291","article-title":"The zinc transporter Slc30a8\/ZnT8 Is required in a subpopulation of pancreatic \u03b1-cells for hypoglycemia-induced glucagon secretion","volume":"290","author":"Solomou","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jtemb.2022.127040_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215485","article-title":"ZnT8 haploinsufficiency impacts MIN6 cell zinc content and \u03b2-Cell phenotype via ZIP-ZnT8 coregulation","volume":"20","author":"Lawson","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtemb.2022.127040_bib95","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.2337\/db13-1882","article-title":"ZnT8-reactive T cells are weakly pathogenic in NOD mice but can participate in diabetes under inflammatory conditions","volume":"63","author":"Nayak","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib96","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00125-009-1438-0","article-title":"Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk","volume":"52","author":"Achenbach","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jtemb.2022.127040_bib97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4274\/jcrpe.galenos.2018.2018.0195","article-title":"SLC30A8 gene rs13266634C\/T polymorphism in children with type 1 diabetes in Tamil Nadu, India","volume":"11","author":"Thirunavukkarasu","year":"2019","journal-title":"J. Clin. Res. Pedia Endocrinol."},{"key":"10.1016\/j.jtemb.2022.127040_bib98","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.cell.2012.02.010","article-title":"Diabetes mellitus and the \u03b2 cell: the last ten years","volume":"148","author":"Ashcroft","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jtemb.2022.127040_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020476","article-title":"Role of zinc homeostasis in the pathogenesis of diabetes and obesity","volume":"19","author":"Fukunaka","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtemb.2022.127040_bib100","doi-asserted-by":"crossref","first-page":"E7642","DOI":"10.1073\/pnas.1721418115","article-title":"Mice harboring the human SLC30A8 R138X loss-of-function mutation have increased insulin secretory capacity","volume":"115","author":"Kleiner","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jtemb.2022.127040_bib101","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/db12-0071","article-title":"ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1","volume":"61","author":"\u00c9n\u00e9e","year":"2012","journal-title":"Diabetes Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib102","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MED.0b013e328308192b","article-title":"New antigenic targets in type 1 diabetes","volume":"15","author":"Wenzlau","year":"2008","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.jtemb.2022.127040_bib103","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1074\/jbc.M116.772152","article-title":"Coupling of insulin secretion and display of a granule-resident zinc transporter ZnT8 on the surface of pancreatic beta cells","volume":"292","author":"Huang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jtemb.2022.127040_bib104","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1074\/jbc.RA117.000195","article-title":"A subclass of serum anti-ZnT8 antibodies directed to the surface of live pancreatic \u03b2-cells","volume":"293","author":"Merriman","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jtemb.2022.127040_bib105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MED.0b013e32833aba41","article-title":"The anti-insulin trimolecular complex in type 1 diabetes","volume":"17","author":"Michels","year":"2010","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.jtemb.2022.127040_bib106","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.diabres.2018.11.007","article-title":"Zinc transporter 8 autoantibodies (ZnT8-ab) are associated with higher prevalence of multiple diabetes-related autoantibodies in adults with type 1 diabetes","volume":"146","author":"Rogowicz-Frontczak","year":"2018","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.jtemb.2022.127040_bib107","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s00125-012-2463-y","article-title":"Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway","volume":"55","author":"S\u00f8rgjerd","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jtemb.2022.127040_bib108","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2337\/dc09-1040","article-title":"Prediction of type 1 diabetes in the general population","volume":"33","author":"Knip","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib109","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1007\/s00125-012-2540-2","article-title":"Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases","volume":"55","author":"Howson","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jtemb.2022.127040_bib110","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/febs.14402","article-title":"The C-terminal cytosolic domain of the human zinc transporter ZnT8 and its diabetes risk variant","volume":"285","author":"Parsons","year":"2018","journal-title":"Febs J."},{"key":"10.1016\/j.jtemb.2022.127040_bib111","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/B978-0-12-394390-3.00008-2","article-title":"Molecular architecture and function of ZnT transporters","volume":"69","author":"Kambe","year":"2012","journal-title":"Curr. Top. Membr."},{"key":"10.1016\/j.jtemb.2022.127040_bib112","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.2337\/db08-0522","article-title":"A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes","volume":"57","author":"Wenzlau","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib113","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2337\/dc11-2081","article-title":"Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies","volume":"35","author":"Yu","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib114","first-page":"1","article-title":"Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?","volume":"66","author":"Lounici Boudiaf","year":"2018","journal-title":"Curr. Res Transl. Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib115","first-page":"379","article-title":"Novel autoantigens in type 1 diabetes","volume":"5","author":"Han","year":"2013","journal-title":"Am. J. Transl. Res"},{"key":"10.1016\/j.jtemb.2022.127040_bib116","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2249.2012.04675.x","article-title":"Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients","volume":"171","author":"Gorus","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib117","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/dmrr.1128","article-title":"The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese","volume":"26","author":"Yang","year":"2010","journal-title":"Diabetes Metab. Res Rev."},{"key":"10.1016\/j.jtemb.2022.127040_bib118","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1399-5448.2012.00916.x","article-title":"Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes","volume":"14","author":"Andersson","year":"2013","journal-title":"Pedia Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib119","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00125-009-1642-y","article-title":"Dimorphic histopathology of long-standing childhood-onset diabetes","volume":"53","author":"Gianani","year":"2010","journal-title":"Diabetologia"},{"issue":"Suppl 4","key":"10.1016\/j.jtemb.2022.127040_bib120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1463-1326.2008.00939.x","article-title":"Relationship between beta-cell mass and diabetes onset","volume":"10","author":"Matveyenko","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jtemb.2022.127040_bib121","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41586-021-04248-x","article-title":"An autoimmune stem-like CD8 T cell population drives type 1 diabetes","volume":"602","author":"Gearty","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jtemb.2022.127040_bib122","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00125-019-04975-x","article-title":"What has zinc transporter 8 autoimmunity taught us about type 1 diabetes","volume":"62","author":"Williams","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jtemb.2022.127040_bib123","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2337\/dc15-1027","article-title":"Positivity for zinc transporter 8 autoantibodies at diagnosis is subsequently associated with reduced \u03b2-cell function and higher exogenous insulin requirement in children and adolescents with type 1 diabetes","volume":"39","author":"Juusola","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib124","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","article-title":"The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study","volume":"58","author":"Krischer","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jtemb.2022.127040_bib125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2017.12.043","article-title":"Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort","volume":"478","author":"Garnier","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jtemb.2022.127040_bib126","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.clinbiochem.2016.06.008","article-title":"Zinc transporter 8 autoantibodies assessment in daily practice","volume":"50","author":"Hussein","year":"2017","journal-title":"Clin. Biochem"},{"key":"10.1016\/j.jtemb.2022.127040_bib127","first-page":"4782","article-title":"The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 diabetes prediction and prevention study","volume":"86","author":"Kimpim\u00e4ki","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jtemb.2022.127040_bib128","doi-asserted-by":"crossref","first-page":"e4638","DOI":"10.1210\/clinem\/dgaa624","article-title":"Dynamics of islet autoantibodies during prospective follow-up from birth to age 15 years","volume":"105","author":"P\u00f6ll\u00e4nen","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jtemb.2022.127040_bib129","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2337\/dc19-2547","article-title":"Hierarchical order of distinct autoantibody spreading and progression to Type 1 diabetes in the TEDDY study","volume":"43","author":"Vehik","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaut.2016.05.010","article-title":"Predictors of slow progression to diabetes in children with multiple islet autoantibodies","volume":"72","author":"Steck","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtemb.2022.127040_bib131","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/08916930903555927","article-title":"ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset","volume":"43","author":"Vaziri-Sani","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jtemb.2022.127040_bib132","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/dme.14261","article-title":"Older age of childhood type 1 diabetes onset is associated with islet autoantibody positivity >30 years later: the Pittsburgh epidemiology of diabetes complications study","volume":"37","author":"Miller","year":"2020","journal-title":"Diabet. Med.: a J. Br. Diabet. Assoc."},{"key":"10.1016\/j.jtemb.2022.127040_bib133","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1056\/NEJMoa1004809","article-title":"Dietary intervention in infancy and later signs of beta-cell autoimmunity","volume":"363","author":"Knip","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib134","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/archpediatrics.2011.1559","article-title":"Removal of Bovine insulin from cow\u2019s milk formula and early initiation of beta-cell autoimmunity in the FINDIA pilot study","volume":"166","author":"Vaarala","year":"2012","journal-title":"Arch. Pedia Adolesc. Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib135","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/diacare.28.5.1068","article-title":"Effects of oral insulin in relatives of patients with type 1 diabetes: the diabetes prevention trial--type 1","volume":"28","author":"Skyler","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib136","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4093\/dmj.2018.0190","article-title":"Latent autoimmune diabetes in adults: a review on clinical implications and management","volume":"42","author":"Pieralice","year":"2018","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.jtemb.2022.127040_bib137","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1007\/s00125-005-1960-7","article-title":"Latent autoimmune diabetes in adults (LADA) should be less latent","volume":"48","author":"Fourlanos","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jtemb.2022.127040_bib138","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1573399814666180730105351","article-title":"Type 1 diabetes-related autoantibodies in different forms of diabetes","volume":"15","author":"S\u00f8rgjerd","year":"2019","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.jtemb.2022.127040_bib139","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/dmrr.2396","article-title":"Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus","volume":"29","author":"Huang","year":"2013","journal-title":"Diabetes Metab. Res Rev."},{"key":"10.1016\/j.jtemb.2022.127040_bib140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/eci.12404","article-title":"GADA and anti-ZnT8 complicate the outcome of phenotypic type 2 diabetes of adults","volume":"45","author":"Haller-Kikkatalo","year":"2015","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.jtemb.2022.127040_bib141","first-page":"25","article-title":"Type LADA diabetes--interrogation points","volume":"70","author":"Otto-Buczkowska","year":"2013","journal-title":"Przegl Lek."},{"key":"10.1016\/j.jtemb.2022.127040_bib142","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/dmrr.2779","article-title":"Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up","volume":"32","author":"Huang","year":"2016","journal-title":"Diabetes Metab. Res Rev."},{"key":"10.1016\/j.jtemb.2022.127040_bib143","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/dc16-0181","article-title":"Reversion of \u03b2-cell autoimmunity changes risk of type 1 diabetes: TEDDY study","volume":"39","author":"Vehik","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib144","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.abb.2016.05.022","article-title":"Zinc and diabetes","volume":"611","author":"Chabosseau","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jtemb.2022.127040_bib145","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-21-0271","article-title":"Lack of ZnT8 protects pancreatic islets from hypoxia- and cytokine-induced cell death","volume":"253","author":"Karsai","year":"2022","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jtemb.2022.127040_bib146","doi-asserted-by":"crossref","first-page":"1524905","DOI":"10.1155\/2019\/1524905","article-title":"Genetic, Functional, and Immunological Study of ZnT8 in Diabetes","volume":"2019","author":"Huang","year":"2019","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.jtemb.2022.127040_bib147","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1074\/jbc.M116.772152","article-title":"Coupling of Insulin Secretion and Display of a Granule-resident Zinc Transporter ZnT8 on the Surface of Pancreatic Beta Cells","volume":"292","author":"Huang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jtemb.2022.127040_bib148","doi-asserted-by":"crossref","first-page":"9083103","DOI":"10.1155\/2016\/9083103","article-title":"Identification of candidate tolerogenic CD8(+) T cell epitopes for therapy of type 1 diabetes in the NOD mouse model","volume":"2016","author":"Yu","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.jtemb.2022.127040_bib149","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar6602","article-title":"Who let the dogs out? The ever-present threat of autoreactive T cells","volume":"3","author":"Ehlers","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib150","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aao4013","article-title":"Islet-reactive CD8 T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors","volume":"3","author":"Culina","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jtemb.2022.127040_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102677","article-title":"Novel autoantibodies to the beta-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes","volume":"122","author":"Gu","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtemb.2022.127040_bib152","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12020-015-0568-z","article-title":"Autocrine effect of Zn\u00b2\u207a on the glucose-stimulated insulin secretion","volume":"50","author":"Slepchenko","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.jtemb.2022.127040_bib153","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41588-019-0513-9","article-title":"Loss of ZnT8 function protects against diabetes by enhanced insulin secretion","volume":"51","author":"Dwivedi","year":"2019","journal-title":"Nat. Genet"},{"key":"10.1016\/j.jtemb.2022.127040_bib154","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng.2915","article-title":"Loss-of-function mutations in SLC30A8 protect against type 2 diabetes","volume":"46","author":"Flannick","year":"2014","journal-title":"Nat. Genet"},{"key":"10.1016\/j.jtemb.2022.127040_bib155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2014-000076","article-title":"Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study","volume":"3","author":"Sorgjerd","year":"2015","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib156","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00592-022-01852-9","article-title":"Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial","volume":"59","author":"Casas","year":"2022","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.jtemb.2022.127040_bib157","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00125-020-05376-1","article-title":"Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial","volume":"64","author":"Assfalg","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.jtemb.2022.127040_bib158","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/pedi.12611","article-title":"Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial","volume":"19","author":"Elding Larsson","year":"2018","journal-title":"Pedia Diabetes"},{"key":"10.1016\/j.jtemb.2022.127040_bib159","doi-asserted-by":"crossref","first-page":"9391845","DOI":"10.1155\/2018\/9391845","article-title":"Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes","volume":"2018","author":"Tavira","year":"2018","journal-title":"J. Diabetes Res"},{"key":"10.1016\/j.jtemb.2022.127040_bib160","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2017.17070","article-title":"for the type 1 Diabetes TrialNet Oral Insulin Study G, Krischer JP, Schatz DA, Bundy B, Skyler JS, Greenbaum CJ, Effect of Oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes: a randomized clinical trial","volume":"318","author":"Writing Committee","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jtemb.2022.127040_bib161","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7779","article-title":"Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes","volume":"9","author":"Alhadj Ali","year":"2017","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib162","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.2015.2928","article-title":"Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial","volume":"313","author":"Bonifacio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jtemb.2022.127040_bib163","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1107096","article-title":"GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus","volume":"366","author":"Ludvigsson","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jtemb.2022.127040_bib164","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(11)60895-7","article-title":"Type 1 Diabetes TrialNet GADSG, Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial","volume":"378","author":"Wherrett","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jtemb.2022.127040_bib165","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2337\/dc11-0523","article-title":"Dpt, TrialNet Study G, Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial","volume":"34","author":"Vehik","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtemb.2022.127040_bib166","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2337\/db10-1360","article-title":"Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes","volume":"60","author":"Fourlanos","year":"2011","journal-title":"Diabetes"}],"container-title":["Journal of Trace Elements in Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X22001201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X22001201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:19:13Z","timestamp":1760555953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0946672X22001201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":166,"alternative-id":["S0946672X22001201"],"URL":"https:\/\/doi.org\/10.1016\/j.jtemb.2022.127040","relation":{},"ISSN":["0946-672X"],"issn-type":[{"value":"0946-672X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antigen-specific immunotherapies in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Trace Elements in Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtemb.2022.127040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"127040"}}